twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2013
vol. 115
 
Share:
Share:
abstract:
Original paper

Botulinum toxin injection as primary treatment for esotropia in patients with cerebral palsy

Malgorzata Mrugacz
1
,
Wojciech Kułak
2
,
Alina Bakunowicz-Łazarczyk
1
,
Artur Bossowski
3

  1. Department of Pediatric Ophthalmology, Medical University of Bialystok, Poland
  2. Department of Pediatric Neurology and Rehabilitation, Medical University of Bialystok, Poland
  3. Department of Pediatric Endocrinology, Diabetology with Cardiology Division, Medical University of Bialystok, Poland
Klinika Oczna 2013, 115 (1): 13-14
Online publish date: 2013/03/28
View full text Get citation
 
Introduction
Botulinum toxin type A is a potent neurotoxin that blocks the release of acetylocholine at the neuromuscular junction of cholinergic nerves. Cerebral palsy is cause of ocular disorders. There is an increased presence of strabismus, refractive errors, and reduced visual acuity. The purpose of this study was to assess the efficacy of botulinum toxin injection in the treatment of esotropia in patients with cerebral palsy.

Material and methods
Seven patients were included in the study. All patients had a full ophthalmic examination on initial visit, including cycloplegic refraction and duction. The angle of esotropic deviation at distance was recorded in prism diopters. The botulinum toxin type A was administered into the medial rectus muscle under general anesthesia.

Results
Mean age of the patients was 12 years. The mean angle of deviation pretreatment was 36.6 PD. Successful motor alignment (orthotropia ± 10 PD) was achieved in the botulinum toxin type A group in 57.1% of patients.

Conclusions
The use of botulinum toxin in the treatment of esotropia in children and adolescents with cerebral palsy is an alternative to conventional surgical therapy.

keywords:

children, strabismus, esotropia, botulinum toxin type A

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.